Kaneh Bosm Announces DTC Eligibility
(firmenpresse) - KANEH BOSM ANNOUNCES DTC ELIGIBILITY
VANCOUVER, British Columbia, September 4, 2018 -- Kaneh Bosm BioTechnolgy Inc. (CSE: KBB)(FWB: 8K51)(OTC: KNHBF)(Kaneh Bosm or the Company) is pleased to announce that it has secured eligibility by The Depository Trust Company (DTC) for its shares on the OTC Markets. DTC is a subsidiary of the Depository Trust & Clearing Corp (DTCC) that manages the electronic clearing and settlement of publicly traded companies in the United States.
Further to the company's news release dated August 14, 2018, Kaneh Bosms common shares are now fully DTC eligible and trade under the symbol KNHBF on the OTC Markets. Securities that are eligible to be electronically cleared and settled through the DTC are considered DTC eligible. This electronic method of clearing securities speeds up the receipt of stock and cash, and thus accelerates the settlement process for investors.
Kaneh Bosms Chief Executive Officer, Eugene Beukman, states, "We are very pleased to have obtained DTC eligibility. This status will make the process of trading our stock in the United States much easier. We expect that this will make our shares available to a larger percentage of the investment market, which should improve the liquidity of our shares and therefore benefit Kaneh Bosm and our shareholders."
On behalf of the Board of Directors of Kaneh Bosm Biotechnology Inc.
Michael Martinz
Michael Martinz
President, Director
mmartinz(at)kanehbosmbiotech.com
Kaneh Bosm BioTechnology Inc.
810 - 789 West Pender Street
Vancouver BC V6C 1H2
Tel: 604.687.2308
THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
This news release includes certain statements that may be deemed forward-looking statements. The use of any of the words anticipate, continue, estimate, expect, may, will, would, project, should, believe and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Companys disclosure documents which can be found under the Companys profile on www.sedar.com
Leseranfragen:
" alt="East Africa Metals Receives Approval of Mine Permit Application for Mato Bula and Da Tambuk Gold Projects">
" alt="Spearmint Acquires the “NEBA West” Gold-Copper Prospect in the Golden Triangle of British Columbia">
Datum: 04.09.2018 - 09:05 Uhr
Sprache: Deutsch
News-ID 580374
Anzahl Zeichen: 2885
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 123 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Kaneh Bosm Announces DTC Eligibility
"
steht unter der journalistisch-redaktionellen Verantwortung von
Kaneh Bosm BioTechnology Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
